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Based on cultural and biochemical tests, a total of 84 strains (72 clinical and 12 environmental isolates from
the Caribbean Isles, Europe, and the Indian subcontinent) were identified as members of the Mycobacterium
avium complex (MAC). They were further characterized with MAC, M. avium, and M. intracellulare probes of
the AccuProbe system, and this was followed by selective amplification of DT6 and DT1 sequences. Seventy
isolates gave concordant results; 63 were identified as M. avium, 5 were identified as M. intracellulare, and 24
remained untypeable by both methods. Fourteen isolates gave discrepant results, as they were DTl positive but
gave negative results by the M. intracellulare AccuProbe test. Consequently, a detailed molecular analysis of all
DT1-positive isolates (14 discrepant strains plus 5 M. intracellulare strains) was performed by PCR-restriction
analysis (PRA) of the hsp65 gene and 16S rRNA gene sequencing. The results confirmed the reported
heterogeneity of M. intracellulare, as only 6 of 19 isolates (32%) gave PRA results compatible with
published M. intracellulare profiles while the rest of the isolates were grouped in four previously unpub-
lished profiles. 16S rRNA gene sequencing showed that only 8 of 19 isolates (4270) were related to M.
intracellulare IWGMT 90247 (EMBL accession no. X88917), the rest being related to MCRO19 (EMBL
accession no. X93030) and MIWGTMR10 (EMBL accession no. X88915). In conclusion, we have character-
ized a significant number of MAC isolates which were not identified by the AccuProbe test, PRA, or 16S rRNA
sequencing. However, all of them were identifiable by DTl-DT6 PCR (they were DT6 negative and DTl positive)
and could be tentatively identified as M. intracellufure based on preliously published observations. It is
noteworthy that the majority of such isolates (14 of 19) were from the Indian subcontinent, with 12 of 14 being
environmental isolates. Our study confirms the marked heterogeneity of-V. intrucellulare isolates and shows the
utility of in-house DTl PCR to detect this group of isolates, which would otherwise have been missed by the
AccuProbe system in a routine clinical microbiology laboratory.
The Mycobactetium avium complex (MAC), which includes
II. Nviunz and M. intracellulare. is a major opportunistic infec-
tion in AIDS patients (22, 23). The diagnosis of MAC organ-
isms remains lengthy due to their slow growth, and results for
identification by cultural and biochemical tests may take as
long as 1 month. Furthermore, additional tests are needed to
further discriminate between the two MAC species and include
hybridization with DNA probes (5, 13, 24, 31), PCR with spe-
c~fic primers (4, 17, 21), amplification of conserved mycobac-
terial sequences followed by either hybridization with species-
specific probes to variable regions within the amplified target
(2, 14) or restriction enzyme analysis (33), and 16s rRNA gene
sequencing (11, 16).
The use of the commercialized AccuProbe Culture Identi-
fication Test (Gen-Probe Inc., San Diego, Calif.) is particularly
suitable for the clinical mycobacteriology laboratory because of
its case and rapidity (12, 38). Although the sensitivity and
specificity of the M. avium probe are reportedly high, many
isolates do not react with the MAC and/or M. intracellulare
probes (18,40,41). Therefore, there is a need for a simple and
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rapid method that is applicable in the routine clinical micro-
biology laboratory and able to identify a majority of MAC
isolates. In this context, both PCR-restriction analysis (PRA)
of the hsp65 gene (33) and DT1-DT6 PCR (8, 34-36) seem
particularly useful.
We recently compared the DT1-DT6 PCR method with the
AccuProbe system and reported the usefulness of DT6 PCR
for easily identiping M. avium isolates (8). In addition, we also
described MAC isolates not reacting with the M. avium and M.
intracellulare probes of the AccuProbe system, which could be
tentatively identified as M. intracellulare by DT1 PCR (8). In
the present study. we extend this information to various other
isolates from the Caribbean Isles and the Indian subcontinent
and report on their molecular characterization with various
probes of the AccuProbe system and by DT1-DT6 PCR, PRA
of a 439-bp region of the hsp65 gene, and 16S rRNA gene
sequencing.
MATERIALS AND METHODS
Origin of isolates. A total of 84 strains (72 clinical and 12 environmental
isolates from the Caribbean Isles, Europe, and the Indian suhcontinent), which
were identified as members of the MAC on the basis of cultural and biochemical
tests (6), were used in this investigation. The Caribbean strains were isolated
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a Results obtained for Caribbean clinical isolates (designations with Gp) and Indian isolates (In 6 and 18, from sputum: In1, 7, 8, 9, 10, 13, and 14, from dust: In3,
5, and 15, from water: and In4 and 11, from soil) are shown.
b AccuProbe tests for MAC, M. avium (MAV), and M. intracellulare (MIN) were performed.
c +, positive; -, negative.
d For further details, please refer to Fig. 4.
Preparation of genomic DNA. The bacterial DNA for DTI-DT6 PCR was
prepared as recently reported (8). Bacterial DNA for PRA was prepared by a
glass bead method: briefly. one loopful of bacteria was suspended in 300 µ1 of TE
(10 mM Tris, 1 mM EDTA) and 100 µl of acid-washed glass beads (diameter.
<106 µm: Sigma, St. Louis, MO.), heated at 94°C for 15 min, and sonicated at 35
kHz for 15 min in a water bath sonicator (Gen-Probe Inc.). An aliquot (5 µl) of
the supernatant containing the crude DNA extract was used for PCR.
PRA. Amplification was performed according to the procedure described by
Telenti et al. (33) using primers Tb11 (5’-ACCAACGATGGTGTGTCCAT-3’)
and Tb12 (5’-CITGTCGAACCGCATACCCT-3’). which amplified a 439-bp
fragment of the hsp65 gene. followed by Bst EII (Promega, Madison, Wis.) and
Hae 111 (BioLabs, Inc., Beverly, Mass.) enzyme digestions of the amplification
product. After digestion, 12 µl of the restriction digest was loaded on a 4%
(wt/vol) NuSieve, 3:1 agarose gel (FMC Bioproducts, Rockland, Maine) and the
gel was electrophoresed in 1 x Tris-acetate-EDTA buffer until the digested
fragments were well separated. PhiX-174-RF DNA Hae III digest (Pharmacia
Biotech, Uppsala, Sweden) served as an external molecular size marker and was
added to every sixth lane of migration to reduce migration-related errors. Frag-
ments were visualized by ethidium bromide fluorescence. and the lengths were
calculated by computer-assisted analysis (28).
The AccuProbe test. MAC, M. avium, and M. intracellulare probes of the
AccuProbe system (Gen-Probe Inc.) were run as reported previously (8, 12, 40).
The results were expressed in relative light units (RLUs) on a Leader-50 lumi-
nometer. A positive reaction was a result greater than the cut-off value of 30,000
RLUs, with a repeat range of 20.000 to 29.999 RLUs. Parallel positive controls
included M. avium ATCC 25291 and M. intracellulare ATCC 13950. M. tubercu-
losis ATCC 25177 served as a negative control for all three probes used.
DTI-DT6 PCR assays. The method used for DT1-DT6 PCR assays was es-
sentially similar to that described previously, with primers AV6 and AV7
(5’-ATGGCCGGGAGACGATCTATGCCGGCGTAC-3’ and 5’-CGTTCGAT
CGCAGTITGTGCAGCGCGTACA-3’. respectively) directing the amplifica-
tion of a 187-bp fragment within the DT6 sequence and primers IN38 and IN41
(5’-GAACGCCCG’ITGGCTGGCCATTCACGAAGGAG-3’ and 5’-GCGCA
ACACGGTCGGACAGGCCTTCCTCGA-3’. respectively) directing the ampli-
fication of a 666-bp fragment within the DTI sequence (8,. 34-36). Each ampli-
fication run included a negative control sample without DNA and a positive
control sample with 2 ng of M. avium ATCC 25291 (serotype 2) for DT6 primers
and 3 ng of M. intracellulare ATCC 13950 (serotype 16) for the DT1 primers (8,
34-36). Half of the amplification reaction mixture was analyzed by electrophore-
sis on a 3% NuSieve, 3:1 agarose gel (FMC BioProducts) with the 100-bp ladder
(Pharmacia Biotech) as a marker. Gels were stained with ethidium bromide and
photographed on a UV transilluminator. Despite the perfect agreement shown
between the results of DT1-DT6 PCR and Southern hybridization analysis with
the entire DT1 and DT6 probes (8, 28, 36), we further reconfirmed all PCR-
negative results by Southern hybridization (8, 28).
16S rRNA gene sequencing. The sequence of the hypervariable fragment A
was determined as reported recently (16.29.42) by the dideoxynucleotide chain
termination method using the Taq DyeDeoxy Terminator Cycle sequencing kit
(Applied Biosystems Division, Perkin-Elmer Corp., Foster City, Calif.) using a
GeneAmp PCR System 9600 (Perkin-Elmer) and a DNA Analysis System 373
Stretch (Applied Biosystems Division, Perkin-Elmer). The results obtained were
entered into a computer, compared to known sequences in the GenBank data-
base, and interpreted by using the BlastN algorithm.
RESULTS
Identification by biochemical tests, the AccuProbe system,
DT1-DT6 PCR, and Southern hybridization. The results of this
investigation are summarized in Table 1 and Fig. 1 to 4. All 54
isolates studied were initially identified as MAC based on their
biochemical and cultural characteristics (6). Although concor-
dant data were obtained for 70 isolates (63 M. avium,. 5 M.
intracellulare, and 2 untypeable isolates [results not shown]), 14
isolates did not give concordant data when typed in parallel by
DT1-DT6 PCR and the AccuProbe system. Surprisingly, all 14
of these isolates were DT1 positive (Fig.1) but did not react
with the M. intracellulare AccuProbe (Table 1). For this reason,
we decided to investigate in more detail all the DT1-positive
FIG. 1. Representative DTI PCR results of some of the MAC isolates from
the Indian subcontinent. Bacterial DNAs were amplified with primers IN38 and
IN41. Lane m, molecular weight marker.
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FIG 2. Representative PRA patterns of DT1 PCR-positive MAC isolates
obtained upon Bst EII (A) and Hae III (B) digestion. Lane M, molecular weight
markers: lane 1, M. intracellulare type strain ATCC 13950, representing PRA
pattern D; lane 2, PRA pattern D; lane 3, PRA pattern B; lanes 4 and 6, PRA
pattern C: lane 5, PRA pattern E: lane 7, PRA pattern A. Please refer to Table
1 and Fig. 3 for further details concerning the representative PRA patterns.
isolates, which included the 14 latter isolates as well as the 5
isolates identified as M. intracellulare by the two initial meth-
ods. As shown in Table 1, all 19 of these isolates gave negative
results by both the M. avium AccuProbe system and DT6 PCR
and were not considered identical to M. avium (8). Further-
more, only 10 of 19 isolates (53%) were MAC AccuProbe
positive.
PRA. PRA, a recently described methodology (33), was val-
idated on type strains of various mycobacterial species. As
results similar to those reported by Telenti et al. (33) were
obtained under our experimental conditions (data not shown),
this methodology was applied to the 19 DT1-positive isolates
shown in Table 1. Only 6 of 19 isolates (32%; 3 of 5 Caribbean
strains and 3 of 14 Indian strains) presented the restriction
profile described by Telenti et al. (33) for M. intracellulare.
Profiles obtained for other isolates did not correspond to those
previously described for any of the mycobacterial species stud-
ied and could be grouped into three distinct PRA profiles by
Bst EII digestion: (i) no digestion. (ii) 245- and 220-bp frag-
ments. and (iii) 245-, 125-, and 100-bp fragments. These groups
were further subdivided into four distinct profiles by Hae III
digestion (patterns A, B, C, and E [Fig. 2 and 3]), in addition
to the one typical profile previously reported for M. intracellu-
lare (pattern D [Fig. 2 and 3]).
16S rRNA gene sequencing. 16S rRNA gene sequencing of
the hypervariable fragment A was performed essentially as
reported earlier for mycobacteria (16, 29, 42), and the results
obtained are summarized in Fig. 4. Overall, eight isolates (5
Caribbean and 3 Indian) (Table 1) were most closely related to
M. intracellulare (EMBL accession no. X88917), a strain re-
cently included in a cooperative study by Wayne et al. (42); 10
isolates were most closely related to MCRO19 (EMBL acces-
sion no. X93030), a strain identified as MAC by biochemical
tests (29); and only a single isolate (strain In 4) was close to
MIWGTMR10 (EMBL accession no. X88915), an isolate
found to be closely related to M. interjectum (42). Therefore, it
can be concluded that all the DT1-positive isolates in the
present study except one showed a certain degree of genetic
homogeneity upon 16S rRNA gene sequencing, constituting
two major groups.
interestingly one of these groups (M. intracellulare X88917)
was constituted of clinical isolates (except a single environmen-
tal isolate, In13) and comprised all five isolates from Guade-
loupe and three of the Indian isolates (Table 1; Fig. 4). An-
other group was composed uniquely of Indian environmental
isolates related to MCRO19 (29). When the results obtained
were entered into a computer and compared to known se-
quences in the GenBank database, the latter group was also
found to be related to isolates as diverse as the unspecified
strain IWGMT 90236 (42). M. scrofulaceum, M. simiae, and M.
intracellulare (results not shown). It should be noted that iso-
lates in this group are clearly distinct from two recently de-
scribed species, M. lentiflavum and M. triplex, that may resem-
ble MAC or M. simiae by biochemical tests (10, 30).
particularly as our isolates were nitrate and urease negative
and harbored 16S rRNA gene sequences distinct from those
reported previously (10. 30).
As the MCRO19 isolate was reportedly closely related to M.
scrofulaceum and M. simiae, we further verified the reported
absence of DT1 fragments in these two species (36) by per-
forming DT1 PCR on various type strains and clinical isolates
of M. simiae and M. scrofulaceum. Since all the isolates were
devoid of the DT1 fragment (results not shown), it was taken
as conclusive evidence to exclude the possibility that our DT1-
positive isolates were variants of M. scrofulaceum and/or M.
simiae.
DISCUSSION
Because of the scarceness of biochemical differences be-
tween M. avium and M. intracellulare (9, 19, 25, 37). additional
techniques, such as high-performance liquid chromatography
(3) and serotyping based on the detection of glycopeptidolipid
antigens (7, 39, 40, 43), have been attempted by reference
laboratories, with the aim of discriminating M. avium from M.
intracellulare; however, such techniques remain cumbersome
and are not easily applicable in most clinical laboratories. Fur-
thermore, serotyping has several drawbacks such as producing
inconsistent data among laboratories and inability to type all
isolates, and is not an optimal method for MAC identification
(11, 24, 32).
Consequently, the aim of the present investigation was to
further characterize isolates initially identified as MAC on the
basis of cultural and biochemical criteria by the AccuProbe
tests. selective amplification of DT6 and DT1 sequences, PRA,
and 16S rRNA gene sequencing. The present investigation is,
therefore, a logical extension of our previous study. showing a
relatively good correlation between DT6 PCR and the M.
avium AccuProbe test (5). As a straightforward correlation
between DT1 PCR and M. intracellulare AccuProbe could not
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FIG. 4. Alignment of 16S rRNA gene sequences of MAC isolates within the hypervariable region A. Nucleotides different from those of M. intracellulare (X88917)
are indicated. The first nucleotide corresponds to Escherichia coli 16S rRNA position 69. Sequence 1. M. intacellulare (X88917); sequence 2, Gp 94025, Gp 94052, Gp
94064, Gp 94070, Gp 94145, and In 6: sequence 3. In 13 and In 18: sequcncc 4, strain MCRO19 (X93030), in 1 In 3, In 5, In 7, In 8, In 10, In 11, In 14, and In 15;
sequence 5, In 9, sequence 6, strain MIWGTMR10 (X88915): sequence 7, In 4.
be well established in the latter study because of the paucity of
DT1- and/or M. intracellulare AccuProbe-positive isolates (only
4 of 69 isolates studied [8]), we further extended this study to
include more DT1 PCR- and/or M. intracellulare AccuProbe-
positive isolates by adding techniques such as PRA and 16S
rRNA gene sequencing.
Since the genetic heterogeneity of MAC organisms other
than the species M. avium is well established (1, 20, 23, 27), it
was logical that our aim was not to study the heterogeneity of
MAC isolates. Instead. we were interested in investigating
whether the DT1 PCR-positive organisms could be included
within MAC (and eventually as M. intracellulare), as most of
them did not react with either the MAC or M. intracellulare
AccuProbes. Such a reaction would have incited a routine
clinical microbiology laboratory performing only the Accu-
Probe test (as is the case for the majority of labs within the
United States and Western Europe) not to classify these iso-
lates as MAC. a possibility which has both clinical and epide-
miological implications.
A detailed analysis of all DT1-positive isolates (14 discrep-
 ant strains plus 5 M. intracellulare strains) was performed by
PRA, a method which was recently reported to be useful in
identifying several mycobacterial species. including M. intracel-
lulare (33). However, the authors used only 12 clinical isolates
of M. intracellulare, all of which were from Western Europe
and had identical PRA profiles (33). In our study, only 6 of 19
isolates (32%) gave PRA results compatible with the previ-
ously published M. intracellulare profile (33), whereas the re-
maining isolates were grouped into four previously unpub-
lished profiles (Table 1: Fi,.g. 2 and 3). It is interesting that all
the isolates with the published M. intracellulare PRA profile
(33) were also simultaneously MAC and M. intracellulare Ac-
cuProbe positive in our study (except a single M. intracellulare
probe-negative isolate [Table 1]). This observation may simply
reflect the fact that Telenti et al. (33) selected uniquely M.
intracellulare isolates reacting positively with the M. intracellu-
lare probe of the AccuProbe system. Facts that may further
contribute to the reported heterogeneity of M. intracellulare
isolates include their geographic origin and the recently re-
ported heterogeneity of the PRA target. Indeed, the sequenc-
ing of the 439-bp portion of hsp65 which is the target of PRA
(32) showed the highest number of alleles for M. intracellulare,
compared to M. scrofulaceum and M. avium (13 sequences
instead of 8 and 7, respectively).
Many strains cannot be included precisely in a taxonomic
group by 16S rRNA gene sequencing alone. Wayne et al.
stated, “there are no universally applicable criteria for deciding
how many base deletions and/or substitutions in 16S rRNA
sequences are sufficient to justify establishment of a new spe-
cies” (42). However, based on criteria defined by Wayne et al.
(42), all the isolates closely related to isolate IWGMT 90247
(EMBL accession no. X8S917) (Table 1 and Fig. 4) were MAC
organisms that could be considered close to M. intracellulare.
Indeed, this group included some isolates that reacted with the
X probe of Syngene but not with the M. intracellulare probe of
the AccuProbe system (42). Thus. when analyzed by 16S rRNA
gene sequencing, only 8 of 19 isolates (425) were related to M.
intracellulare IWGMT 90247 (EMBL accession no. X88917) in
our study. The remaining 10 of 19 isolates were related to
MCRO19 (a strain identified as MAC by biochemical tests
[29]). and only a single isolate was close to MIWGTMR10 (an
isolate that was difficult to classify and was hypothesized to be
a ribovar and/or subspecies of M. interjectum [42]).
Thus. if a clinical microbiology laboratory aims to detect all
the MAC isolates in a clinical setting. it is clear that contrary to
DT1 PCR, which did not fail to detect any of the 19 isolates
studied here (considered 100% detection). M. intracellulare
AccuProbe, PRA, 16S rRNA gene sequencing. and the MAC
AccuProbe would detect only 26, 32, 42, and 53% of the iso-
lates, respectively. In conclusion, we have characterized a sig-
nificant number of MAC isolates which were identified by
neither the AccuProbe test, PRA, nor 16S rRNA gene se-
quencing but were grouped together by DT1-DT6 PCR (they
were DT6 negative and DT1 positive) and tentatively identified
as M. intracellulare based on previously published observations
(8, 28, 34-36). It is noteworthy that the majority of such iso-
lates (14 of 19) were from the Indian subcontinent, with 12 of
14 being environmental isolates. Our results therefore confirm
the marked heterogeneity of MAC isolates related to M. intra-
cellulare (36) and show the utility of in-house DT1 PCR to
detect this group of isolates, which would otherwise have been
missed by the AccuProbe system in a routine clinical microbi-
ology laboratory.
VOL. 35, 1997 MOLECULAR CHARACTERIZATION OF MAC 2771
ACKNOWLEDGEMENTS
The mycobacterium project in Guadeloupe received financial sup-
port from the Délégation Générale au Réseau International des Insti-
tuts Pasteur et Instituts Associés, Institut Pasteur, Paris, France, and
the Fondation Française Raoul Follereau, Paris, France. N.R. is grate-
ful to Gen Probe-France (Chatillon, France) for loan of a Leader-50
luminotmeter, A.D. was awarded a Ph.D. fellowship from the Ministry
of Education and Research, Paris, France, and M.P. received an
ANRS research fellowship (Agence Nationale de Recherches sur le
SIDA, Paris. France).
B. T. Mangura, L. B. Reichman, L. B. Heifets, B. Dautzenberg, L. S. Young,
L. E. M. Bermudez, C. D. Inderlied, A. E. Suzuki, J. M. Inamine, P. R. J.
Gangadharam, M. V. Reddy, M. Denis, H. Shiratsuchi, J. L. Johnson, J. J.
Ellner, J. T. Belisle, and P. J. Brennan. 1994,. 11th Forum in Microbiology,
“Laboratory and clinical aspects of the Mycobacterium avium epidemic: con-
tributing factors associated with variability of drug susceptibility and immune-
responsiveness, and the multifaceted nature of pathogenicity.” Res. Micro-
biol, 145: l67-261.
23. Rastogi, N.,  J. J. McFadden, M. L. Gougeon, L. Montagnier, F. M. Collins,
C. R. Horsburgh, R. J. Coker, T. J. Hellyer, I. N. Brown, J. N. Weber, I. M.
Orme, D. Chatterjee, J. D. A. Van Embden, D. Van Soolingen, P.M. Small,
P. W. M. Hermans, S. E. Hoffner, G. Källenius, S. B. Swenson, R. S. Wallis,
J.J.  Ellner, H. Shiratsuchi, G. .A. W. Rook, A. Vyakarnam, D. M. Yajko, L. S.
Young, L. E. M. Bermudez, C. B. Inderlied, Z. M. Kunze, F. Portaels, and V.
Labrousse. 1992, 8th Forum in Microbiology, “Mycobacteria and AIDS
epidemiological and genetic markers, virulence factors and interactions with
the immune system.” Res. Microbilol. 143: 357-440.
Saito, H., H. Tomioka, K. Sato, H. Tasaka, and D. J. Danson. 1990. Iden-
tification of various serovar strains of Mycobacterium avium complex by using
DNA probes specific for Mycobacterium avium and Mycobacterium intracel-
lulare. J. Clin. Microbiol. 28: 1694-1697.
Sato, K., H. Tomioka, and H. Saito. 1992. Differential susceptibilities of
Mycobacterium avium and Mycobacterium intracellulare to sodium nitrite.























Böddinghaus, B., T. Rogall, T. Flohr, H. Blöcker, and E. C. Böttger. 1990.
Detection and identification of mycobacteria by amplification of rRNA. J.
Clin. Microbiol. 28: 1751-1759.
Butler, W. R., and J. O. Kilburn. 1988. Identification of major slowly patho-
genic mycobacteria and Mycobacterium gordonae by high-performance liquid
chromatography of their mycolic acids. J. Clin. Microbiol. 26: 50-53.
Chen, Z.-H., W. R. Butler, B. R. Baumstark, and D. G. Ahearn. 1996.
Identification and differentiation of Mycobacterium avium and M. intracellu-
lare by PCR. J. Clin. Microbiol. 34: 1267-1269.
Crawford, J. T. 1994. Development of rapid techniques for identification of
M. avium infections. 11th Forum in Microbiology. Res. Microbiol. 145: 177-
181.
David. H., V. Levy-Frébault, and M.-F. Thorel. 1989. Méthodes de labora-
toire pour mycobactériologie clinique. Institut Pasteur, Paris, France.
Denner. J. C., A Y. Tsang, D. Chatterjee, and P. Brennan. 1992. Compre-
hensive approach to identification of serovars of Mycobacterium avium com-
plex. J. Clin. Microbiol. 30: 473-478.
Devallois, .A., M. Picardeau, K. S. Goh, C. Sola, V. Vincent. and N. Rastogi.
1996. Comparative evaluation of PCR and commercial DNA probes for
detection and identification to species level of Mycobacterium avium and M.
intracellulare. J. Clin. Microbiol. 34: 2756-2759.
Falkinham, J. O., III. 1990. Arylsulfatase activity of Mycobacterium avium,
M. intracellulare. and M. scrofulaceum. Int. J. Syst. Bacteriol. 40: 66-70.
Floyd, M. M., L. S. Guthertz, V. A. Silcox, P. S. Duffey, Y. Jang, E. P.
Desmond, J. T. Crawford, and W. R. Butler. 1996. Characterization of an
SAV organism and proposal of Mycobacterium triplex sp. nov. J. Clin. Mi-
crobiol. 34: 2963-2967.
Frothingham, R., and K. H. Wilson. 1993. Molecular phylogeny of the
Mycobacterium avium complex demonstrates clinically meaningful divisions.
J. Infect. Dis. 169: 305-312.
Gen-Probe Inc. 1992. AccuProbe TM Mycobacterium avium, , Mycobacterium
intracellulare culture identification test. p. 14,. In Manual for in vitro diag-
nostic use. Gen-Probe Inc., San Diego, Calif.
Guerrero, C.. C. Bernasconi, D. Burki, T. Bodmer, and A. Telenti. 1995. A
novel insertion element from Mycobacterium avium, IS1245, is a specific
target for analysis of strain relatedness. J. Clin. Microbiol. 33: 304-307.
Hance, A. J., B. Grandchamp, V. Levy-Frébault, D. Lecossier, J. Rauzier, D.
Bocart, and B. Gicquel. 1989. Detection and identification of mycobacteria
by amplification of mycobacterial DNA. Mol. Microbiol. 3: 843-849.
Kamala, T., C. N. Paramasivan, D. Herbert, P. Venkatesan, and R. Prab-
hakar. 1994 Isolation and identification of environmental mycobacteria in
the Mycobacterium bovis BCG trial area of South India. Appl. Environ.
Microbiol. 60: 2180-2183.
Kirschner, P., A. Meier, and E. C. Böttger. 1993. Genotypic identification
and detection of mycobacteria. p. 173-190. In D. H. Persing, T. F. Smith,
F. C. Tenover, and T. J. White (cd.). Diagnostic molecular microbiology,
American Society for Microbiology, Washington. D.C.
Kulski, J. K., C. Khinsoe, T. Pryce, and K. Christiansen. 1995. Use of a
multiplex PCR to detect and identify Mycobacterium avium and M. intracel-
lulare in blood culture fluids of AIDS patients. J. Clin. Microbiol. 33: 668-
674.
Lebrun, L., F. Espinasse, J. Poveda, and V. Vincent-Levy-Frebault. 1992.
Evaluation of nonradioactive DNA probes for identification of mycobacte-
ria. J. Clin. Microbiol. 30: 2476-2478.
Mayer, B. K., and J. O. Falkinham III. 1986. Catalase activity and heat
inactivation for differentiation of M. avium, M. intracellulare, and M. scrofu-
laceum. Int. J. Syst. Bacteriol. 36: 207-212.
McFadden, J. J., Z. M. Kunze, F. Portaels, V. Labrourse, and N. Rastogi.
1992. Epidemiological and genetic markers, virulence factors and intracel-
lular growth of Mycobacterium avium in AIDS. Res. Microbiol. 143: 423-430.
Nishimori, K., M. Eguchi, Y. Nakaoka, Y. Onodera, T. Ito, and K. Tanaka.
1995. Distribution of IS901 in strains of Mycobacterium avium complex from
swine by using IS901- detecting primers that discriminate between M. avium
and Mycobacterium intracellulare. J. Clin. Microbiol. 33: 2102-2106.



















Smet, K. A. L. D.. T. J. Hellyer, A.W. Khan, I. S. Brown, and J. Ivanyi. 1996.
Genetic and serovar typing of clinical isolates of the Mycobacterium avium-
intracellulare complex. Tubercle Lung Dis. 77: 71-76.
Soini, H., E. Eerola, and M. K. Viljanen. 1996. Genetic diversity among
Mycobacterium avium complex AccuProhe-positive isolates. J. Clin. Micro-
biol. 34: 55-57.
Sola, C.. A. Deallois, K. S. Goh, E. Legrand, and S. Rastogi. 1996. Molec-
ular characterization of Mycobacterium avium complex isolates from Carib-
bean patients using DT1 DT6-PCR, nonradioactive southern hybridization
and the Accuprobe system. Curr. Microbiol. 33: 352-358.
Springer, B., L. Stockman, K. Teschner, G. D. Roberts, and E. C. Böttger.
1996. Two-laboratory collaborative study on identification of mycobacterial
molecular versus phenotypic methods. J. Clin. Microbiol. 34: 296-303.
Springer, B., W.-K. Wu, T. Bodmer, G. Haase, G. E. Pfyffer, R. M. Krop-
penstedt, K.-H. Schröder, S. Emler, J. O. Kilburn, P. Kirschner, A. Telenti,
M. B. Coyle, and E. C. Böttger. 1996, Isolation and characterization of
unique group of slowly growing mycobacteria: description of Mycobacterium
lentiflavum sp. nov. J. Clin. Microbiol. 34: 1100-1107.
Sritharan, V., J. V. Iralu, and R. H. Barker. Jr. 1995. Specificity of diagnostic
PCR amplification for M. avium using the probe pMAV22. Mol. Cell. Probes.
9: 71-74.
Swanson, D. S., S. Pan. and J. M. Musser. 1996. Identification and subspe-
cific differentiation of Mycobacterium scrofulaceum by automated sequencing
of a region of the gene (hsp65) encoding a 65-kilodalton heat shock protein.
J. Clin. Microbiol. 34: 3151-3159.
Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Böttger, and T. Bodmer.
1993. Rapid identification of mycobacteria to the species level by polymerase
chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31: 175-
178.
Thierry, D., S. Baugé, J.-D. Paveda, V. Vincent. and J.-L. Guesdon. 1993.
Rapid identification  of Mycobacterium avium-intracellulare complex strains:
clinical practice evaluation of DT6 and DT1 probes. J. Infect. Dis. 168: 1337-
1338.
Thierry, D., P. Matsiota-Bernard, C. Nauciel, and J.-L. Guesdon. 1994
Comparison of polymerase chain reaction and non-radioactive hybridization
techniques for the identification of Mycobacterium avium strains. Mol. Cell.
Probes 8: 469-471.
Thierry, D., V. Vincent, F. Clement, and J.-L. Guesdon. 1993. Isolation of
specific DNA fragments of Mycobacterium avium and their possible use in
diagnosis. J. Clin. Microbiol. 31: 1048-1054.
Tomioka, H., H. Saito, K. Sato, and D. J. Damson. 1990. Arylsulfatase activity
for differentiating Mycobacterium avium and Mycobacterium intracellulare.
J. Clin. Microbiol. 28: 2104-2106.
2772 DEVALLOIS ET AL. J. CLIN. MICROBIOL.
42. Wayne, L. G., R. C. Good, E. C. Böttger, H. Butler, M. Dorsch, T. Ezaki, W. 43. Wayne, L. G., R. C. Good, A. Tsang, R. Butler, D. Dawson, D. Groothuis, W.
Gross, V. Jonas, J. Kilburn, P. Kirschner, M. I. Krichevsky, M. Ridell,T. M. Gross, J. Hawkins, J. Kilburn, M. Kubin, K. H. Schröder, V. A. Silcox, C.
Schinnick, B. Springer, E. Stackebrandt, I.Tarnok, Z. Tamok, H.Tasaka,V. Smith, M.-F. Thorcl, C. Woodley, and M. A. Yakrus. 1993. Serovar deter-
Vincent, N. G. Warren, C. A. Knott, and R. Johnson. 1996. Semantide- and mination and molecular taxonomic correlation in Mycobacterium avium , M.
chemotaxonomy-based analyses of some problematic phenotypic clusters of intracellulare, and Mycobacterium scrofulaceum: a cooperative study of the
slowly growing mycobactcria, a cooperative study of the international work- International working group on mycobacterial taxonomy. Int. J. Syst. Bacte-
ing group on mycobactcrial taxonomy. Int. J. Syst. Bacteriol. 46: 280-297. riol. 43: 482-489.
